Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alterity Therapeutics Limited (ATHE)

2.06   -0.03 (-1.44%) 09-29 10:43
Open: 2.09 Pre. Close: 2.09
High: 2.09 Low: 2.045
Volume: 4,104 Market Cap: 37M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.124 - 2.134 2.134 - 2.143
Low: 2.005 - 2.017 2.017 - 2.028
Close: 2.051 - 2.07 2.07 - 2.087

Technical analysis

as of: 2020-09-29 10:08:13 AM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.67     One year: 3.00
Support: Support1: 1.83    Support2: 1.52
Resistance: Resistance1: 2.29    Resistance2: 2.57
Pivot: 2.11
Moving Average: MA(5): 2.02     MA(20): 2.11
MA(100): 1.51     MA(250): 1.09
MACD: MACD(12,26): -0.03     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 32.03     %D(3): 27.29
RSI: RSI(14): 46.83
52-week: High: 5.15  Low: 0.28  Change(%): 91.7
Average Vol(K): 3-Month: 213593  10-Days: 16150

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ATHE has closed above bottom band by 38.5%. Bollinger Bands are 30.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 17 Sep 2020
Where Will Alterity Therapeutics Ltd (ATHE) Stock Go Next After It Is Up 13.94% in a Week? - InvestorsObserver

Thu, 17 Sep 2020
Arrowhead Hits the Bullseye in Phase 2 Study of ARO-AAT; Analyst Targets Over 90% Upside - Nasdaq

Thu, 17 Sep 2020
40 Stocks Moving In Thursday's Mid-Day Session - benzinga.com

Tue, 08 Sep 2020
Should Alterity Therapeutics Ltd (ATHE) be in Your Portfolio? - InvestorsObserver

Wed, 05 Aug 2020
Alterity Therapeutics Ltd (ATHE) Stock: What Does the Chart Say? - InvestorsObserver

Tue, 04 Aug 2020
Stock Alert: Alterity Therapeutics Surges To New 52-week High - Nasdaq

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18
Shares Float (M) 12
% Held by Insiders
% Held by Institutions 1.96
Shares Short (K) 218
Shares Short P. Month (K) 80

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin -296.16
Operating Margin
Return on Assets (ttm) -58.4
Return on Equity (ttm) -113.5
Qtrly Rev. Growth
Gross Profit (p.s.) -0.020
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.